Why is Titan Biotech falling/rising?

As of 14-Jul, Titan Biotech Ltd's stock price is currently at 464.80, reflecting an increase of 2.3 (0.5%). The stock has shown a positive trend recently, gaining 2.15% over the last two days and outperforming its sector by 1.11%. However, despite this short-term gain, the stock has experienced a significant decline year-to-date, down 36.57%, and has underperformed the market over the past year with a return of -22.68%. The company has high management efficiency with a return on equity (ROE) of 25.08%, but it also faces challenges such as negative results for the last three consecutive quarters and a high valuation compared to its peers, which may contribute to investor caution.
In the broader market context, Titan Biotech's recent performance contrasts with the Sensex, which has seen a decline of 1.42% over the past week, while Titan Biotech has gained 1.93% in the same timeframe. This indicates that the stock is currently performing better than the overall market. However, the stock's long-term growth prospects appear poor, with net sales and operating profit growth rates lagging behind expectations, and a significant drop in profits over the last year. This combination of short-term gains against a backdrop of long-term challenges may create a mixed sentiment among investors.